2026 NPPES data Pulmonary Disease Physician NPI 1336633072 MD
Verify on CMS →

Mark Dunlop, MD

Pulmonary Disease Physician in Riverside, Rhode Island.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,647 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
146
Medicare Part D claims · 32 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
39%
generic claims · 61% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

Mark Dunlop, MD filed 146 Medicare Part D claims in 2024 as a Pulmonary Disease Physician in Riverside, Rhode Island, prescribing 39% generic.

146
Part D claims, 2024
39%
generic prescribing
≥34th
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Mark Dunlop, MD

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1336633072), first enumerated 06/17/2018.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 146 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    Board certification signal

    Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.

    Source: NUCC taxonomy + CMS participation heuristic

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1336633072 · Pulmonary Disease Physician

NPI-10 · ENUM-RECENT · TAX-MID · RX-LIGHT · BOOK-THIN · PHOTO-ENUM

  • NPI-10 1336633072
  • ENUM-RECENT 2018
  • TAX-MID 10K Pulmonary Disease
  • RX-LIGHT 146
  • BOOK-THIN 48 in Rhode Island
  • PHOTO-ENUM Suraj Shah · 2018

Mark Dunlop, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

146 ≥ 34th percentile 34% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). This entry sits in this band. 200–400: 188,835 prescribers (13%). Above this entry. 400–600: 95,866 prescribers (7%). Above this entry. 600–800: 60,107 prescribers (4%). Above this entry. 800–1,000: 43,043 prescribers (3%). Above this entry. 1,000–1,200: 33,612 prescribers (2%). Above this entry. 1,200–1,400: 27,889 prescribers (2%). Above this entry. 1,400–1,600: 23,183 prescribers (2%). Above this entry. 1,600–1,800: 19,917 prescribers (1%). Above this entry. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

Board-eligible specialty (heuristic, not verified)

Mark Dunlop, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Mark Dunlop, MD?

Quality data not reported

NPI registry status

Active

Issued 06/17/2018

NPI 1336633072

Primary specialty

Pulmonary Disease Physician

Mid-sized

9,647 US NPIs in this specialty

Medicare Part D claims

146 90% vs specialty avg

2024 prescription claims

Specialty avg: 1,498

Specialty distribution in Rhode Island

How Pulmonary Disease Physician compares to other specialties among Rhode Island providers

Rhode Island providers
Clinical Social Worker8.9%Mental Health Counselor5.3%Physical Therapist4.7%Student in an Organized Heal…4.6%Internal Medicine Physician4.2%Pharmacist4.1%Pulmonary Disease Physician0.2%
Largest specialties in Rhode Island (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pulmonary Disease Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

375 WAMPANOAG TRL
Riverside, RI 02915

Provider Details

NPI 1336633072
Specialty Pulmonary Disease Physician
Credentials MD
Gender Male
NPI Issued 06/17/2018

Brand vs generic prescribing mix · Brand-heavy

Mark Dunlop, MD - brand share 61.0%
Pulmonary Disease Physician average

61% brand-name claims vs 39% generic, on 146 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

146
Total Claims
$29K
Total Drug Cost
32
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
196.367
Total Day Supply
5,440
Brand vs Generic
61% brand / 39% generic
Brand Drug Cost
$28K
Generic Drug Cost
$1K

Patient Demographics

Average Patient Age
71.1 years
Avg HCC Risk Score
2.42
Gender Split
66% female / 34% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Mark Dunlop, MD prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Albuterol Sulfate Hfa
Albuterol Sulfate
32
Budesonide-Formoterol Fumarate
Budesonide/Formoterol Fumarate
17
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
16
Fluticasone Propionate
12
Methotrexate
Methotrexate Sodium
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pulmonary Disease Physician Overview

How Mark Dunlop, MD fits within the Pulmonary Disease Physician landscape nationally.

9,647
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,498
Avg Claims per Provider

Mark Dunlop, MD's 146 claims are below the specialty average of 1,498.

Nationwide Pulmonary Disease Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Dunlop, both outside Rhode Island so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2018)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Pulmonary Disease Physician Providers in Rhode Island

Other clinicians with the same primary specialty enrolled in Rhode Island, drawn from the same CMS NPPES roster as Dunlop.

One of 48 Pulmonary Disease Physician providers enrolled in Rhode Island, 5 are shown here.

Compare Pulmonary Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Mark Dunlop, MD's specialty?
Mark Dunlop, MD specializes in Pulmonary Disease Physician and practices in Riverside, Rhode Island. Credentials: MD.
How much does Mark Dunlop, MD prescribe under Medicare Part D?
In 2024, Mark Dunlop, MD wrote 146 Medicare Part D claims totaling $29K in drug costs for 32 beneficiaries.
Where is Mark Dunlop, MD located?
Mark Dunlop, MD is located at 375 WAMPANOAG TRL, Riverside, RI, 02915. Phone: (401) 649-4080.
What is Mark Dunlop, MD's NPI number?
Mark Dunlop, MD's National Provider Identifier (NPI) is 1336633072, issued on 06/17/2018.
Does Mark Dunlop, MD prescribe more brand-name or generic drugs?
Mark Dunlop, MD's prescribing is 61% brand-name and 39% generic drugs by claim count, with $28K in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US?
There are 9,647 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,498 Medicare Part D claims per year.
What drugs does Mark Dunlop, MD prescribe most often?
Based on 2024 Medicare Part D data, Mark Dunlop, MD's most frequently prescribed drugs include Albuterol Sulfate Hfa, Budesonide-Formoterol Fumarate, Trelegy Ellipta. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mark Dunlop, MD accept Medicare?
Mark Dunlop, MD appears in CMS Medicare data with 146 Part D claims and 32 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mark Dunlop, MD's credentials?
Mark Dunlop, MD's NPI is 1336633072 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.